1. Home
  2. SYNX vs CELZ Comparison

SYNX vs CELZ Comparison

Compare SYNX & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silynxcom Ltd.

SYNX

Silynxcom Ltd.

HOLD

Current Price

$1.07

Market Cap

7.3M

Sector

N/A

ML Signal

HOLD

CELZ

Creative Medical Technology Holdings Inc.

HOLD

Current Price

$0.89

Market Cap

7.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYNX
CELZ
Founded
2005
1998
Country
Israel
United States
Employees
37
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
7.8M
IPO Year
2023
2008

Fundamental Metrics

Financial Performance
Metric
SYNX
CELZ
Price
$1.07
$0.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.4K
8.1M
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.08
EPS
N/A
N/A
Revenue
N/A
$6,000.00
Revenue This Year
$32.35
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.79
52 Week High
$2.15
$6.25

Technical Indicators

Market Signals
Indicator
SYNX
CELZ
Relative Strength Index (RSI) 44.81 28.72
Support Level $1.04 $0.79
Resistance Level $1.25 $2.33
Average True Range (ATR) 0.07 0.43
MACD 0.00 -0.07
Stochastic Oscillator 34.44 2.82

Price Performance

Historical Comparison
SYNX
CELZ

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sells push-to-talk devices, communication controllers, and communication device cables and connectors. Geographically, it generates the majority of its revenue from Israel.

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.

Share on Social Networks: